Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
New York Wholesale Group is voluntarily recalling Zaarah Herbals Shatavari Powder due to the potential for contamination with elevated levels of lead. This recall affects product batches distributed between October 2022 and April 2024 in New York, New Jersey, and Connecticut.
The recall was initiated after an analysis by the Connecticut Department of Consumer Protection revealed that the Shatavari Powder contained unsafe levels of lead. Although no illnesses have been reported, lead exposure, even in small amounts, can pose serious health risks, especially for pregnant women, young children, and adults with chronic exposure.
Health Risks of Lead Contamination
Lead exposure can have severe long-term effects on health. For children and fetuses, even low levels of lead can cause developmental delays, learning disabilities, and permanent damage to the central nervous system. For adults, prolonged exposure is associated with kidney dysfunction, high blood pressure, increased risk of cardiovascular disease, and neurocognitive problems.
The recall specifically impacts the Zaarah Herbals Shatavari Powder packaged in 100g (3.5oz) jars with a gold lid. The affected product is identified by the UPC code 63502899940 and Batch No: SR 04, with a Manufacturing Date of July 2022. The product label clearly displays the brand name and product name on the front of the jar.
What Consumers Should Do
Consumers who have purchased Zaarah Herbals Shatavari Powder should immediately stop using the product and return it to the retailer for a full refund. The recall applies to products purchased between October 2022 and April 2024 in New York, New Jersey, and Connecticut.
For additional information or questions regarding the recall, consumers can contact New York Wholesale Group at 1-800-516-7606, Monday through Friday, from 10:00 am to 6:00 pm EST.
The company urges all consumers who have purchased the affected product to act promptly to ensure their health and safety. As always, consumers should consult with their healthcare provider if they have concerns about potential exposure to lead or any related health issues.
No illnesses have been reported thus far, but New York Wholesale Group is taking this step out of an abundance of caution to protect consumers from potential risks associated with lead exposure.
